Plain-English translation of NCT04244630 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Phase 2 โ Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether a combination of over-the-counter vitamins and supplements โ including vitamin E, NAC cysteine, L-cystine, nicotinamide, and taurusodiol โ can slow down the progression of ALS. The study will enroll 60 people with ALS and track whether this medication helps preserve muscle strength and function over about 13 months. Right now, there are very few effective treatments for ALS, so researchers are testing whether this combination approach might help.
ALS is a rapidly progressive disease with few effective treatments available. Current approved medications only extend survival by a few weeks or help a small number of patients. This trial exists because researchers believe that using multiple vitamins and supplements together โ rather than just one medication โ might be a safe, affordable way to slow the disease's progression.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You would take daily doses of vitamins and supplements at home as directed by the study team. Over about 13 months, you would visit the study center for regular check-ins to assess how you're doing and whether the treatment is helping slow your symptoms. The study team will monitor your muscle strength, weight, and overall health to see if this combination of supplements makes a difference in slowing ALS progression.
AI-generated summary from trial data ยท Jun 1, 2026 ยท Not medical advice
United States